Therapeutic Potential Targeting Podocyte Mitochondrial Dysfunction in Focal Segmental Glomerulosclerosis
Open Access
- 28 March 2023
- journal article
- review article
- Published by S. Karger AG in Kidney Diseases
- Vol. 9 (4) , 254-264
Abstract
Background: Podocytes are essential components of the glomerular filtration barrier and essential for the proper filtration function of the glomerulus. Podocyte injury under various stress conditions is the primary pathogenesis and key determinant of focal segmental glomerulosclerosis (FSGS) with prominent clinical manifestations of proteinuria or nephrotic syndrome. Summary: Under physiological conditions, a highly coordinated mitochondrial quality control system, including antioxidant defenses, mitochondrial dynamics (fusion, fission, and mitophagy), and mitochondrial biogenesis, guarantees the sophisticated structure and various functions of podocytes. However, under FSGS pathological conditions, mitochondria encounter oxidative stress, dynamics disturbances, and defective mitochondrial biogenesis. Moreover, mutations in mitochondrial DNA and mitochondria-related genes are also strongly associated with FSGS. Based on these pieces of evidence, bioactive agents that function to relieve mitochondrial oxidative stress and promote mitochondrial biogenesis have been proven effective in preclinical FSGS models. Targeting the mitochondrial network is expected to provide new therapeutic strategies for the treatment of FSGS and delay its progression to end-stage renal disease. Key Messages: Mitochondrial dysfunction plays a key role in podocyte injury and FSGS progression. This review summarized recent advances in the study of mitochondrial homeostatic imbalance and dysfunction in FSGS and discussed the potential of mitochondria-targeted therapeutics in improving FSGS and retarding its progression to end-stage renal disease.Keywords
This publication has 103 references indexed in Scilit:
- Cyclosporine A-induced apoptosis in renal tubular cells is related to oxidative damage and mitochondrial fissionToxicology Letters, 2013
- Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injuryKidney International, 2012
- The β2-Adrenoceptor Agonist Formoterol Stimulates Mitochondrial BiogenesisThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Acatalasemic mice are mildly susceptible to adriamycin nephropathy and exhibit increased albuminuria and glomerulosclerosisBMC Nephrology, 2012
- Role of Intrarenal Angiotensin System Activation, Oxidative Stress, Inflammation, and Impaired Nuclear Factor-Erythroid-2-Related Factor 2 Activity in the Progression of Focal GlomerulosclerosisThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Podocyte Glutamatergic Signaling Contributes to the Function of the Glomerular Filtration BarrierJournal of the American Society of Nephrology, 2009
- Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2American Journal of Physiology-Renal Physiology, 2008
- COQ2 NephropathyJournal of the American Society of Nephrology, 2007
- Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosisKidney International, 2006
- Podocyte Depletion Causes GlomerulosclerosisJournal of the American Society of Nephrology, 2005